Maria A Nagel1, Teresa White1, Nelly Khmeleva1, April Rempel1, Philip J Boyer2, Jeffrey L Bennett3, Andrea Haller4, Kelly Lear-Kaul5, Balasurbramaniyam Kandasmy2, Malena Amato6, Edward Wood7, Vikram Durairaj6, Franz Fogt8, Madhura A Tamhankar9, Hans E Grossniklaus10, Robert J Poppiti11, Brian Bockelman11, Kathy Keyvani12, Lea Pollak13, Sonia Mendlovic14, Mary Fowkes15, Charles G Eberhart16, Mathias Buttmann17, Klaus V Toyka17, Tobias Meyer-ter-Vehn18, Vigdis Petursdottir19, Don Gilden20. 1. Department of Neurology, University of Colorado School of Medicine, Aurora. 2. Department of Pathology, University of Colorado School of Medicine, Aurora. 3. Department of Neurology, University of Colorado School of Medicine, Aurora3Department of Ophthalmology, University of Colorado School of Medicine, Aurora. 4. Fort Wayne Neurological Center, Fort Wayne, Indiana. 5. Arapahoe County Coroner's Office, Centennial, Colorado. 6. Texas Oculoplastic Consultants, Austin. 7. Texas Oculoplastic Consultants, Austin7University of Texas Southwestern-Austin Transitional Year Program, Austin. 8. Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia. 9. Scheie Eye Institute, University of Pennsylvania, Philadelphia. 10. Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia. 11. A. M. Rywlin Department of Pathology, Mount Sinai Medical Center and Florida International University, Miami. 12. Institute of Neuropathology, University of Duisburg-Essen, Essen, Germany. 13. Department of Neurology, Assaf Harofeh Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 14. Pathological Institute, Assaf Harofeh Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 15. Department of Pathology, Icahn School of Medicine, Mount Sinai Health System, New York, New York. 16. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland. 17. Department of Neurology, University of Würzburg, Würzburg, Germany. 18. Department of Ophthalmology, University of Würzburg, Würzburg, Germany. 19. Landspitali University Hospital, Reykjavik, Iceland. 20. Department of Neurology, University of Colorado School of Medicine, Aurora20Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora.
Abstract
IMPORTANCE: Giant cell arteritis (GCA) is the most common systemic vasculitis in elderly individuals. Diagnosis is confirmed by temporal artery (TA) biopsy, although biopsy results are often negative. Despite the use of corticosteroids, disease may progress. Identification of causal agents will improve outcomes. Biopsy-positive GCA is associated with TA infection by varicella-zoster virus (VZV). OBJECTIVE: To analyze VZV infection in TAs of patients with clinically suspected GCA whose TAs were histopathologically negative and in normal TAs removed post mortem from age-matched individuals. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional study for VZV antigen was performed from January 2013 to March 2015 using archived, deidentified, formalin-fixed, paraffin-embedded GCA-negative, GCA-positive, and normal TAs (50 sections/TA) collected during the past 30 years. Regions adjacent to those containing VZV were examined by hematoxylin-eosin staining. Immunohistochemistry identified inflammatory cells and cell types around nerve bundles containing VZV. A combination of 17 tertiary referral centers and private practices worldwide contributed archived TAs from individuals older than 50 years. MAIN OUTCOMES AND MEASURES: Presence and distribution of VZV antigen in TAs and histopathological changes in sections adjacent to those containing VZV were confirmed by 2 independent readers. RESULTS: Varicella-zoster virus antigen was found in 45 of 70 GCA-negative TAs (64%), compared with 11 of 49 normal TAs (22%) (relative risk [RR] = 2.86; 95% CI, 1.75-5.31; P < .001). Extension of our earlier study revealed VZV antigen in 68 of 93 GCA-positive TAs (73%), compared with 11 of 49 normal TAs (22%) (RR = 3.26; 95% CI, 2.03-5.98; P < .001). Compared with normal TAs, VZV antigen was more likely to be present in the adventitia of both GCA-negative TAs (RR = 2.43; 95% CI, 1.82-3.41; P < .001) and GCA-positive TAs (RR = 2.03; 95% CI, 1.52-2.86; P < .001). Varicella-zoster virus antigen was frequently found in perineurial cells expressing claudin-1 around nerve bundles. Of 45 GCA-negative participants whose TAs contained VZV antigen, 1 had histopathological features characteristic of GCA, and 16 (36%) showed adventitial inflammation adjacent to viral antigen; no inflammation was seen in normal TAs. CONCLUSIONS AND RELEVANCE: In patients with clinically suspected GCA, prevalence of VZV in their TAs is similar independent of whether biopsy results are negative or positive pathologically. Antiviral treatment may confer additional benefit to patients with biopsy-negative GCA treated with corticosteroids, although the optimal antiviral regimen remains to be determined.
IMPORTANCE: Giant cell arteritis (GCA) is the most common systemic vasculitis in elderly individuals. Diagnosis is confirmed by temporal artery (TA) biopsy, although biopsy results are often negative. Despite the use of corticosteroids, disease may progress. Identification of causal agents will improve outcomes. Biopsy-positive GCA is associated with TA infection by varicella-zoster virus (VZV). OBJECTIVE: To analyze VZV infection in TAs of patients with clinically suspected GCA whose TAs were histopathologically negative and in normal TAs removed post mortem from age-matched individuals. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional study for VZV antigen was performed from January 2013 to March 2015 using archived, deidentified, formalin-fixed, paraffin-embedded GCA-negative, GCA-positive, and normal TAs (50 sections/TA) collected during the past 30 years. Regions adjacent to those containing VZV were examined by hematoxylin-eosin staining. Immunohistochemistry identified inflammatory cells and cell types around nerve bundles containing VZV. A combination of 17 tertiary referral centers and private practices worldwide contributed archived TAs from individuals older than 50 years. MAIN OUTCOMES AND MEASURES: Presence and distribution of VZV antigen in TAs and histopathological changes in sections adjacent to those containing VZV were confirmed by 2 independent readers. RESULTS:Varicella-zoster virus antigen was found in 45 of 70 GCA-negative TAs (64%), compared with 11 of 49 normal TAs (22%) (relative risk [RR] = 2.86; 95% CI, 1.75-5.31; P < .001). Extension of our earlier study revealed VZV antigen in 68 of 93 GCA-positive TAs (73%), compared with 11 of 49 normal TAs (22%) (RR = 3.26; 95% CI, 2.03-5.98; P < .001). Compared with normal TAs, VZV antigen was more likely to be present in the adventitia of both GCA-negative TAs (RR = 2.43; 95% CI, 1.82-3.41; P < .001) and GCA-positive TAs (RR = 2.03; 95% CI, 1.52-2.86; P < .001). Varicella-zoster virus antigen was frequently found in perineurial cells expressing claudin-1 around nerve bundles. Of 45 GCA-negative participants whose TAs contained VZV antigen, 1 had histopathological features characteristic of GCA, and 16 (36%) showed adventitial inflammation adjacent to viral antigen; no inflammation was seen in normal TAs. CONCLUSIONS AND RELEVANCE: In patients with clinically suspected GCA, prevalence of VZV in their TAs is similar independent of whether biopsy results are negative or positive pathologically. Antiviral treatment may confer additional benefit to patients with biopsy-negative GCA treated with corticosteroids, although the optimal antiviral regimen remains to be determined.
Authors: Maria A Nagel; Nelly Khmeleva; Philip J Boyer; Alexander Choe; Robert Bert; Don Gilden Journal: J Neurol Sci Date: 2013-10-02 Impact factor: 3.181
Authors: Richard Salazar; Andrew N Russman; Maria A Nagel; Randall J Cohrs; Ravi Mahalingam; D Scott Schmid; Bette K Kleinschmidt-DeMasters; Eve M VanEgmond; Don Gilden Journal: Arch Neurol Date: 2011-04
Authors: Nicholas L Baird; Jacqueline L Bowlin; Xiaoli Yu; Stipan Jonjić; Jürgen Haas; Randall J Cohrs; Don Gilden Journal: Virology Date: 2014-05-05 Impact factor: 3.616
Authors: Tiago Teodoro; Maria A Nagel; Ruth Geraldes; Teresa White; Ravi Mahalingam; Paulo Batista; Mary Wellish; Jose Pimentel; Nelly Khmeleva; Anna Heintzman; Luísa Albuquerque; Philip J Boyer; Alexander Choe; Rita Peralta; Don Gilden Journal: J Neurol Sci Date: 2014-05-27 Impact factor: 3.181
Authors: Liliya Golas; Jeffrey L Bennett; Teresa M White; Barry Skarf; Robert Lesser; Maria A Nagel; Don Gilden Journal: Ophthalmology Date: 2015-06-06 Impact factor: 12.079
Authors: Don Gilden; Teresa White; Nelly Khmeleva; Anna Heintzman; Alexander Choe; Philip J Boyer; Charles Grose; John E Carpenter; April Rempel; Nathan Bos; Balasubramaniyam Kandasamy; Kelly Lear-Kaul; Dawn B Holmes; Jeffrey L Bennett; Randall J Cohrs; Ravi Mahalingam; Naresh Mandava; Charles G Eberhart; Brian Bockelman; Robert J Poppiti; Madhura A Tamhankar; Franz Fogt; Malena Amato; Edward Wood; Vikram Durairaj; Steve Rasmussen; Vigdis Petursdottir; Lea Pollak; Sonia Mendlovic; Denis Chatelain; Kathy Keyvani; Wolfgang Brueck; Maria A Nagel Journal: Neurology Date: 2015-02-18 Impact factor: 9.910
Authors: Don Gilden; Teresa M White; Lidia Nagae; William H Gurdin; Philip J Boyer; Maria A Nagel Journal: JAMA Neurol Date: 2015-08 Impact factor: 18.302
Authors: Marc Mathias; Maria A Nagel; Nelly Khmeleva; Philip J Boyer; Alexander Choe; Vikram D Durairaj; Jeffrey L Bennett; Naresh Mandava; Don Gilden Journal: J Neurol Sci Date: 2013-01-11 Impact factor: 3.181
Authors: Maria A Nagel; Jeffrey L Bennett; Nelly Khmeleva; Alexander Choe; April Rempel; Philip J Boyer; Don Gilden Journal: Neurology Date: 2013-05-01 Impact factor: 9.910
Authors: Elisabeth De Smit; Eoin O'Sullivan; David A Mackey; Alex W Hewitt Journal: Graefes Arch Clin Exp Ophthalmol Date: 2016-08-05 Impact factor: 3.117
Authors: Leonard H Calabrese; Fenglong Xie; Huifeng Yun; Kevin L Winthrop; John W Baddley; Cassandra Calabrese; Jeffrey R Curtis Journal: Arthritis Rheumatol Date: 2017-02 Impact factor: 10.995
Authors: Christian Dejaco; Elisabeth Brouwer; Justin C Mason; Frank Buttgereit; Eric L Matteson; Bhaskar Dasgupta Journal: Nat Rev Rheumatol Date: 2017-09-14 Impact factor: 20.543
Authors: Anna M Blackmon; Christina N Como; Andrew N Bubak; Teresa Mescher; Dallas Jones; Maria A Nagel Journal: J Infect Dis Date: 2019-09-26 Impact factor: 5.226